Heart Valve Disease: State of the Art
Editat de Jose Zamorano, Patrizio Lancellotti, Luc Pierard, Philippe Pibaroten Limba Engleză Paperback – 27 noi 2020
Heart Valve Disease: State of the Art is dedicated to provide up-to-date knowledge to clinical and interventional cardiologists, cardiovascular imagers and cardiac surgeons. It provides state-of-the-art information for the health-care professional working in heart valve clinics, heart teams, and centers of excellence that specialize in managing patients with heart valve disease.
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (1) | 575.13 lei 39-44 zile | |
| Springer International Publishing – 27 noi 2020 | 575.13 lei 39-44 zile | |
| Hardback (1) | 875.36 lei 18-23 zile | +75.71 lei 7-13 zile |
| Springer International Publishing – 27 noi 2019 | 875.36 lei 18-23 zile | +75.71 lei 7-13 zile |
Preț: 575.13 lei
Preț vechi: 605.40 lei
-5% Nou
Puncte Express: 863
Preț estimativ în valută:
110.07€ • 116.12$ • 91.73£
110.07€ • 116.12$ • 91.73£
Carte tipărită la comandă
Livrare economică 30 decembrie 24 - 04 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783030231064
ISBN-10: 3030231062
Pagini: 279
Ilustrații: X, 279 p. 133 illus., 123 illus. in color.
Dimensiuni: 178 x 254 mm
Greutate: 0.66 kg
Ediția:1st ed. 2020
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
ISBN-10: 3030231062
Pagini: 279
Ilustrații: X, 279 p. 133 illus., 123 illus. in color.
Dimensiuni: 178 x 254 mm
Greutate: 0.66 kg
Ediția:1st ed. 2020
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
Cuprins
How to evaluate a patient with valve disease The Heart Team The Valve Center.- Aortic Valve Stenosis Epidemiology Clinical presentation Diagnosis Echo Cath MRI Other imaging modalities Treatment. What do the guidelines say Future directions.- Aortic Regurgitatio Epidemiology Clinical presentation Diagnosis Echo Cath MRI Other imaging modalities Treatment. What do the guidelines say Future directions.- Mitral Stenosis Epidemiology Clinical presentation Diagnosis Echo Cath MRI Other imaging modalities Treatment. What do the guidelines say Future directions.- Mitral regurgitation Epidemiology Clinical presentation Diagnosis Echo Cath MRI Other imaging modalities Treatment. What do the guidelines say Future directions .- Tricuspid Stenosis Epidemiology Clinical presentation Diagnosis Echo Cath MRI Other imaging modalities Treatment. What do the guidelines say Future directions.- Tricuspid regurgitation Epidemiology Clinical presentation Diagnosis Echo Cath MRI Other imaging modalitiesTreatment. What do the guidelines say Future directions .- Pulmonar stenosis Epidemiology Clinical presentation Diagnosis Echo Cath MRI Other imaging modalities Treatment. What do the guidelines say Future directions .- Pulmonary Regurgitation Epidemiology Clinical presentation Diagnosis Echo Cath MRI Other imaging modalities Treatment. What do the guidelines say Future directions .- Endocarditis Clinical presentation Diagnosis Echo Cath MRI Other imaging modalities Treatment. What do the guidelines say .- Imaging inside the cath lab. TAVI Before the intervention. What to do? During the intervention. How to assess complications. How to follow .- Mitral valve interventions for Regurgitation Before the intervention. What to do? During the intervention. How to assess complications. How to follow Future directions.- Mitral valve interventions for Stenosis Before the intervention. What to do? During the intervention. How to assess complications. How to follow .- tricuspid valve interventions Before the intervention. What to do? During the intervention. How to assess complications. How to follow Future directions .- Pulmonary valve interventions Before the intervention. What to do? During the intervention. How to assess complications. How to follow Future directions.
Notă biografică
José Luis Zamorano is Professor of Medicine at the University Alcala in Madrid and Director of the Cardiovascular department at the University Hospital Ramon y Cajal, Madrid. His key research interests include ischaemic heart disease, cardiovascular risk factors and imaging modalities. Professor Zamorano is Past President of the European Association of Echocardiography (EAE) and Past President of the Working Group on Non-invasive Diagnostic Imaging of the Spanish Society of Cardiology. Currently Vice president of the European Society of Cardiology. He served on numerous Editorial Boards, including the European Journal of Echocardiography, the American Society of Echocardiography and the European Heart Journal. He has authored over 400 articles for peer-reviewed journals. He gained his MD from the University Complutense in 1987.
Patricio Lanzelloti is a pioneer in the field of valvular heart disease. He has published several papers related to the main topic of the present book and is part of the guidelines writing group on valvular heart disease. He has already co-edited several books including the secondary mitral regurgitation with Khalil Fattouch.
Luc Pierard is honorary Professor of Medicine at the University of Liège, Belgium and was Head of the Department of Cardiology of the University Hospital Sart Tilman in Liège from 2002 to 2017. He was the first to demonstrate the utility of dobutamine stress echocardiography for identifying myocardial viability and ischemia and to use exercise echocardiography in valvular heart diseases. He was President of the Belgian Society of Cardiology and had several positions in the European Society of Cardiology: he chaired the Working Group on Echocardiography and is currently chairperson of the ESC Council in Valvular Heart Disease. He is Editor-in-Chief of Acta Cardiologica and Senior Associate Editor of the EHJ Cardiovascular Imaging. He has published more than 400 peer-reviewed articles (many on valvular heart disease) and more than 50 book chapters.
Philippe Pibarot is professor at the Department of Medicine of Laval University and holds the Canada Research Chair in Valvular Heart Disease (VHD) at the Québec Heart & Lung Institute. He has published more than 500 articles and presented >800 invited conferences in the course of his career and he is among the most influential scientists in the field of Medicine according to the Clarivate Analytics Highly Cited Researchers 2018. He received the Research Achievement Award, Canadian Cardiovascular Society (2010) and a Doctorate Honoris Causa of University of Liège, Belgium (2017).
Textul de pe ultima copertă
This book provides a state-of-the-art description of the pathophysiology, diagnosis and management of valvular heart disease (VHD). With an aging population, the incidence and complexity of VHD has markedly increased and the introduction of transcatheter valve therapies have revolutionized the management of these frequent and serious cardiovascular diseases. The development of percutaneous valve interventions has revolutionized the management of VHD (or has dramatically changed its management)
Heart Valve Disease: State of the Art is dedicated to provide up-to-date knowledge to clinical and interventional cardiologists, cardiovascular imagers and cardiac surgeons. It provides state-of-the-art information for the health-care professional working in heart valve clinics, heart teams, and centers of excellence that specialize in managing patients with heart valve disease.
Heart Valve Disease: State of the Art is dedicated to provide up-to-date knowledge to clinical and interventional cardiologists, cardiovascular imagers and cardiac surgeons. It provides state-of-the-art information for the health-care professional working in heart valve clinics, heart teams, and centers of excellence that specialize in managing patients with heart valve disease.
Caracteristici
Provides state of the art instruction on the management of valve disease Reveals the current state of diagnosis, treatment and follow-up of patients Describes the new devices and their most appropriate uses when treating structural heart diseases